A membrane-based ELISA assay and electrochemical immunosensor for microcystin-LR in water samples

We describe within this paper the development of an affinity sensor for the detection of the cyanobacterial toxin microcystin-LR. The first stage of the work included acquiring and testing of the antibodies to this target. Following the investigation, a heterogeneous direct competitive enzyme-linked immunosorbent assay (ELISA) format for microcystin-LR detection was developed, achieving a detection limit, LLD(80) = 0.022 μg L(-1). The system was then transferred to an affinity membrane sorbent-based ELISA. This was an amenable format for immunoassay incorporation into a disposable amperometric immunosensor device. This membrane-based ELISA achieved a detection limit, LLD(80) = 0.06 μg L(-1). A three-electrode immunosensor system was fabricated using thick-film screen-printing technology. Amperometric horseradish peroxidase transduction of hydrogen peroxide catalysis, at low reducing potentials, versus Ag/AgCl reference and carbon counter electrodes, was facilitated by hydroquinone-mediated electron transfer. A detection limit of 0.5 μg L(-1) for microcystin-LR was achieved. Similar levels of detection could be obtained using direct electrochemical sensing of the dye produced using the membrane-based ELISA. These techniques proved to be simple, cost-effective, and suitable for the detection of microcystin-LR in buffer and spiked tap and river water samples.

Toxicology and risk assessment of freshwater cyanobacterial (blue-green algal) toxins in water

The occurrence of cyanobacterial toxins affects aquatic organisms, terrestrial animals (both wild and domestic), and humans. Detrimental effects have been documented in the scientific literature during the past 50 years. Possible guideline values of some cyanobacterial toxins (microcystins, cylindrospermopsin, and anatoxin-a) are estimated, and they show that children and infants are more susceptible to cyanobacterial toxins than adults. Therefore, particular attention should be paid when cyanobacterial blooms occur, even at relatively low cell counts, to protect children and infants from possible risks. Based on these guideline values and the occurrence of the toxins, it can be concluded that chronic and subchronic exposure to cyanobacterial toxins does occur in some populations, particularly in developing countries where high proportions of the population consume untreated surface water directly, such as pond, ditch, river, or reservoir water. Because wildlife and domestic animals consume a large amount of untreated water daily, they are at higher risk than humans from cyanobacterial toxins. Calculated guideline values in Section X show that a relatively high risk posed by the toxins to these animals is likely to occur, even at low cell densities.

Use of a rapid bioluminescence assay for detecting cyanobacterial microcystin toxicity

The recent rise in the awareness of the occurrence of toxic cyanobacterial blooms in aquatic environments, with associated human health problems and animal deaths, has increased the need for rapid, reliable and sensitive methods of determining cyanobacterial toxicity. A luminescent bacterial toxicity test was assessed as a complement to the established mouse bioassay. Seventeen samples including pure cyanobacterial microcystin-LR hepatotoxin, laboratory isolates and natural blooms of cyanobacteria were tested and toxicity data compared with mouse LD50 values. Microcystin-LR and all five microcystin-containing cyanobacterial samples, hepatotoxic by mouse test gave EC50 values of less than 0.46 mg/ml in bioluminescence-based Microtox assays. Of 11 samples non-toxic by mouse bioassay, only two gave an EC50 of less than 0.98 mg/ml by bioluminescence assay. It is suggested that the Microtox bioluminescence assay may prove useful in the preliminary screening of cyanobacterial blooms for microcystin-based toxicity.